INMB earnings: a negative outcome, -6.9%

On March 3, 2022, INmune Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.9% in the window around the event. It had already run -15.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.